Inhibition of Mutated BRAF in Melanoma.

被引：0
|
作者：
Kim, Taegyun [1 ]
Kim, Jihyun [1 ]
Lee, Min-Geol [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 363卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2261 / 2261
页数：1
相关论文
共 50 条
  • [41] BRAF, NRAS, and KIT mutational analysis of spindle cell melanoma.
    Dorkhom, S. J.
    Kim, J.
    Lazar, A. J. F.
    Davies, M. A.
    Homsi, J.
    Papadopoulos, N. E.
    Hwu, W.
    Bedikian, A. Y.
    Woodman, S. E.
    Patel, S. P.
    Hwu, P.
    Kim, K. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Impact of BRAF mutation in patients with brain metastasis from melanoma.
    Venur, Vyshak Alva
    Kotecha, Rupesh
    Chen, Zhijian
    Chao, Samuel T.
    Elson, Paul
    Suh, John H.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
    Long, G. V.
    Stroyakovskiy, D.
    Gogas, H.
    Levchenko, E.
    de Braud, F.
    Larkin, J.
    Garbe, C.
    Jouary, T.
    Hauschild, A.
    Grob, J. J.
    Sileni, V. Chiarion
    Lebbe, C.
    Mandala, M.
    Millward, M.
    Arance, A.
    Bondarenko, I.
    Haanen, J. B. A. G.
    Hansson, J.
    Utikal, J.
    Ferraresi, V.
    Kovalenko, N.
    Mohr, P.
    Probachai, V.
    Schadendorf, D.
    Nathan, P.
    Robert, C.
    Ribas, A.
    DeMarini, D. J.
    Irani, J. G.
    Casey, M.
    Ouellet, D.
    Martin, A. -M.
    Le, N.
    Patel, K.
    Flaherty, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1877 - 1888
  • [44] Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
    Larkin, James
    Ascierto, Paolo A.
    Dreno, Brigitte
    Atkinson, Victoria
    Liszkay, Gabriella
    Maio, Michele
    Mandala, Mario
    Demidov, Lev
    Stroyakovskiy, Daniil
    Thomas, Luc
    de la Cruz-Merino, Luis
    Dutriaux, Caroline
    Garbe, Claus
    Sovak, Mika A.
    Chang, Ilsung
    Choong, Nicholas
    Hack, Stephen P.
    McArthur, Grant A.
    Ribas, Antoni
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1867 - 1876
  • [45] Overcoming drug resistance in BRaf mutated melanoma cells
    Samadani, Ramin
    Zhang, Jun
    Mackerell, Alexander
    Fletcher, Steven
    Shapiro, Paul
    CANCER RESEARCH, 2014, 74 (19)
  • [46] Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma
    Kim, Jenna May
    Weiss, Sarah
    Sinard, John H.
    Pointdujour-Lim, Renelle
    OCULAR ONCOLOGY AND PATHOLOGY, 2020, 6 (01) : 35 - 38
  • [47] Sequence Therapy in BRAF- mutated dedifferentiated Melanoma
    Bergner, I.
    Zillikens, D.
    Terheyden, P.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 52 - 52
  • [48] Development of encorafenib for BRAF-mutated advanced melanoma
    Koelblinger, Peter
    Thuerigen, Olaf
    Dummer, Reinhard
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (02) : 125 - 133
  • [49] Current State of Target Treatment in BRAF Mutated Melanoma
    Tanda, Enrica Teresa
    Vanni, Irene
    Boutros, Andrea
    Andreotti, Virginia
    Bruno, William
    Ghiorzo, Paola
    Spagnolo, Francesco
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [50] Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors
    Dolinsek, Tanja
    Prosen, Lara
    Cemazar, Maja
    Potocnik, Tjasa
    Sersa, Gregor
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 274 - 279
12345